Displaying items by tag: department of neurosurgery

The fields of neuroengineering and brain-computer interfaces could have a tremendous impact on a number of neurologic conditions, such as stroke, neurodegenerative disorders, Parkinson’s disease, dementia and other brain diseases.
The grant will fund research surrounding next-generation human models that could potentially aid in the development of treatment for glioblastoma.
UAB’s new intraoperative MRI suite allows for real time magnetic resonance imaging during surgical procedures.

At UAB, the company IN8bio Inc. is running a Phase I clinical trial to treat glioblastoma multiforme, the most aggressive type of cancer that originates in the brain.

The new grant links UAB researchers with colleagues at two other institutions to search for ways to advance therapies from bench to bedside.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
A small molecule inhibitor has been identified that reduces the growth of uveal melanoma, a rare and deadly cancer of the eye.
G207, an immunotherapy derived from a modified herpes virus is well tolerated in children with gliomas, and shows signs of clinical effectiveness
The study points to an adhesive cell surface protein that might be a key element in tackling the resistance to radiation therapy commonly seen in glioblastoma tumors.
James Markert, M.D., MPH, the James Garber Galbraith Endowed Chair of Neurosurgery at the University of Alabama at Birmingham, is the president-elect of the American Academy of Neurological Surgery for 2020-2021.
With misinformation about COVID-19 vaccines rife, turn to trusted medical professionals at UAB’s Department of Medicine for the straight dope.
Migraine headaches were ruining Christopher Sheheane’s life, until a visit to UAB found the cause: a pituitary gland tumor.
Physicians say it is crucial for trainees to have role models and mentors who have shared experiences.
This is thought to be the first time that information found via artificial intelligence has led to a clinical trial.

Case studies show five people who found better treatments for neuropsychiatric symptoms from data collected while patients were at home.

Page 1 of 3